Heron Therapeutics (HRTX) Other Operating Expenses (2012 - 2026)
Heron Therapeutics' (HRTX) quarterly Other Operating Expenses came in at $2.4 million in Q1 2026, up 4.65% YoY from $2.3 million in Q1 2025, and down 80.5% on a QoQ basis from $12.2 million in Q4 2025.
Heron Therapeutics (HRTX) Other Operating Expenses (2012 - 2026) Analysis & Trends
Heron Therapeutics (HRTX) has 14 years of Other Operating Expenses data on file, last reported at $2.4 million in Q1 2026.
- Quarterly Other Operating Expenses rose 4.65% year-over-year to $2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30.5 million (down 49.55% YoY) and the FY2025 annual result came in at $49.1 million, up 4.2% from the prior year.
- Other Operating Expenses eased to $2.4 million in Q1 2026, from $12.2 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $53.4 million in Q1 2022 to a low of $2.3 million in Q1 2025.
- A 5-year average of $18.1 million and a median of $13.0 million in 2023 frame the typical range for Other Operating Expenses.
- Annual changes were most pronounced in 2024 — Other Operating Expenses jumped 330.4% — and 2025, when it slumped 80.08%.
- Tracing HRTX's Other Operating Expenses over 5 years: stood at $18.0 million in 2022, then plunged by 56.57% to $7.8 million in 2023, then jumped by 330.4% to $33.6 million in 2024, then plunged by 63.57% to $12.2 million in 2025, then plunged by 80.5% to $2.4 million in 2026.
- The last three Other Operating Expenses figures came in at $2.4 million (Q1 2026), $12.2 million (Q4 2025), and $12.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Heron Therapeutics | 59.96 Mn | 17.29 Mn | 26.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.70 Mn |
| Mar 31, 2026 | 2.39 Mn |
| Dec 31, 2025 | 12.23 Mn |
| Sep 30, 2025 | 12.94 Mn |
| Jun 30, 2025 | 2.93 Mn |
| Mar 31, 2025 | 2.28 Mn |
| Dec 31, 2024 | 33.58 Mn |
| Sep 30, 2024 | 10.97 Mn |
| Jun 30, 2024 | 13.61 Mn |
| Mar 31, 2024 | 11.44 Mn |
| Dec 31, 2023 | 7.80 Mn |
| Sep 30, 2023 | 12.96 Mn |
| Jun 30, 2023 | 21.21 Mn |
| Mar 31, 2023 | 21.15 Mn |
| Dec 31, 2022 | 17.97 Mn |
| Sep 30, 2022 | 25.55 Mn |
| Jun 30, 2022 | 45.01 Mn |
| Mar 31, 2022 | 53.43 Mn |
| Dec 31, 2021 | 79.07 Mn |
| Sep 30, 2021 | 36.56 Mn |